DUBLIN–(BUSINESS WIRE)–March 7, 2022–
the “China Acetylcysteine Market Survey Report 2021-2025” report has been added to ResearchAndMarkets.comoffer.
According to the analysis, the sales value of acetylcysteine grew rapidly from 2016 to 2019 in China, with the highest annual growth rate of 47.93% in 2019.
In 2020, the sales value of acetylcysteine increased by approximately 8.84% to CNY 1.016 billion in China. The main reason is that the Covid-19 outbreak has affected the hospital’s overall diagnosis and treatment business, causing its growth rate to decline. The CAGR of the sales value of acetylcysteine in the Chinese market from 2016 to 2020 is 24.74%.
Acetylcysteine, also known as N-acetylcysteine (NAC), is a medication used to treat an overdose of paracetamol (acetaminophen) and to loosen thick mucus in people with chronic bronchopulmonary disorders like pneumonia and bronchitis . Acetylcysteine was originally patented in 1960 and came into medical use in 1968.
Its FLUIMUCIL product was developed by Zambon Italia Srl. Acetylcysteine was approved in China in 2002. As of mid 2021, in addition to Zambon Italia Srl, there are more than 10 generic drug manufacturers in China’s acetylcysteine market, such as Hangzhou Minsheng Pharmaceutical Co., Ltd., Hainan Star Pharmaceutical Co., Ltd. and Ruiyang Pharmaceutical Co., Ltd.
The analyst predicts that acetylcysteine sales in the Chinese market will experience restorative growth from 2021 to 2025 with the effective easing of the Covid-19 outbreak. In addition, Kangyuan Pharmaceutical submitted a marketing authorization application for acetylcysteine inhalation solution on March 16, 2021.
The price of acetylcysteine is expected to decrease with the addition of new manufacturers. There is room for growth in both sales volume and sales.
- The impact of COVID-19 on the Chinese acetylcysteine market
- China Acetylcysteine Sales Value 2016-2020
- Competitive Landscape of China Acetylcysteine Market
- Acetylcysteine Price in China
- Acetylcysteine Price in China by Regions and Manufacturers
- Analysis of factors affecting the development of the Chinese acetylcysteine market
- China Acetylcysteine Market Outlook 2021 to 2025
Main topics covered:
1 Relevant concepts of acetylcysteine
1.1 Indications for acetylcysteine
1.2 Acetylcysteine Development in China
1.3 Government Approval of Acetylcysteine in China
1.4 COVID-19’s impact on China Acetylcysteine Sales
2 China Acetylcysteine Sales, 2016-2020
2.1 Acetylcysteine Sales Value
2.1.1 Overall sales value
2.1.2 Sales Value by Regions
2.2 Acetylcysteine Sales Volume
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 China Acetylcysteine Sales by Dosage Form, 2016-2020
2.3.5 Effervescent tablets
2.3.6 Solution for inhalation
3 Analysis of Acetylcysteine Key Manufacturers in China, 2016-2020
3.1 Acetylcysteine Key Manufacturers Market Share Analysis
3.1.1 Market Share Survey by Sales Value
3.1.2 Market Share Survey by Sales Volume
3.2 Hangzhou Minsheng Pharmaceutical Co., Ltd.
3.2.1 Company profile
3.2.2 China Asixintai (Acetylcysteine of Hangzhou Minsheng Pharmaceutical Co., Ltd.) Sales
3.3 Zambon Italia S.r.l.
3.3.1 Company Profile
3.3.2 China FLUIMUCIL (Acetylcysteine by Zambon Italia Srl) Sales
3.4 Hainan Star Pharmaceutical Co., Ltd.
3.4.1 Company Profile
3.4.2 China Boqing (Acetylcysteine of Hainan Star Pharmaceutical Co., Ltd.) Sales
3.5 Ruiyang Pharmaceutical Co., Ltd.
3.5.1 Business Profile
3.5.2 China Kebining (Ruiyang Pharmaceutical Co., Ltd.’s Acetylcysteine) Sales
3.6 Hainan Zambon Pharmaceutical Co., Ltd.
3.6.1 Company Profile
3.6.2 China FLUIMUCIL (Acetylcysteine from Hainan Zambon Pharmaceutical Co., Ltd.) Sales
4 Acetylcysteine Price for Different Manufacturers in China, 2020
4.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. (Asixintai)
4.2 Zambon Italia Srl (FLUIMUCIL)
4.3 Hainan Star Pharmaceutical Co., Ltd. (Boqing)
4.4 Ruiyang Pharmaceutical Co., Ltd. (Kebining)
4.5 Hainan Zambon Pharmaceutical Co., Ltd. (FLUIMUCIL)
5 China Acetylcysteine Market Outlook, 2021-2025
5.1 Factors Influencing the Development of China Acetylcysteine Market
5.1.1 The impact of COVID-19 on the China Acetylcysteine Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Market Size Forecast
5.3 Market Trend Forecast
For more information on this report, visit https://www.researchandmarkets.com/r/rd449
Show source version on businesswire.com:https://www.businesswire.com/news/home/20220307005822/en/
Laura Wood, Senior Press Officer
[email protected] EST business hours, call 1-917-300-0470
For US/CAN call toll free 1-800-526-8630
For GMT office hours call +353-1-416-8900
KEYWORD: CHINA ASIA PACIFIC
INDUSTRY KEYWORD: MANAGED CARE HOSPITALS HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright BusinessWire 2022.
PUBLISHED: 03/07/2022 12:24 PM / DISK: 03/07/2022 12:24 PM